首页> 美国卫生研究院文献>EFSA Journal >ECDC EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food‐producing animals
【2h】

ECDC EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food‐producing animals

机译:ECDCEFSA和EMA联合科学意见关于监测人类和食用动物的抗菌素耐药性和抗菌素消耗的一系列成果指标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

, and have jointly established a list of harmonised outcome indicators to assist Member States in assessing their progress in reducing the use of antimicrobials and antimicrobial resistance ( ) in both humans and food‐producing animals. The proposed indicators have been selected on the basis of data collected by Member States at the time of publication. For humans, the proposed indicators for antimicrobial consumption are: total consumption of antimicrobials (limited to antibacterials for systemic use), ratio of community consumption of certain classes of broad‐spectrum to narrow‐spectrum antimicrobials and consumption of selected broad‐spectrum antimicrobials used in healthcare settings. The proposed indicators for in humans are: meticillin‐resistant and 3rd‐generation cephalosporin‐resistant , resistant to aminoglycosides, fluoroquinolones and 3rd‐generation cephalosporins, resistant to penicillin and resistant to macrolides, and resistant to carbapenems. For food‐producing animals, indicators for antimicrobial consumption include: overall sales of veterinary antimicrobials, sales of 3rd‐ and 4th‐generation cephalosporins, sales of quinolones and sales of polymyxins. Finally, proposed indicators for in food‐producing animals are: full susceptibility to a predefined panel of antimicrobials in , proportion of samples containing ‐/AmpC‐producing , resistance to three or more antimicrobial classes in and resistance to ciprofloxacin in . For all sectors, the chosen indicators, which should be reconsidered at least every 5 years, are expected to be valid tools in monitoring antimicrobial consumption and . With the exception of the proposed human indicators, the indicators are in general not suitable to monitor the effects of targeted interventions in a specific sector, such as in a single animal species or animal production sector. Management decisions should never be based on these indicators alone but should take into account the underlying data and their analysis.
机译:,并共同建立了统一的成果指标清单,以协助会员国评估其在减少人类和粮食生产动物对抗菌素和抗菌素耐药性的使用方面的进展。拟议指标是根据会员国在发布时收集的数据选择的。对于人类,拟议的抗菌药物消费指标为:抗菌药物的总消费(仅限于全身使用的抗菌药物),某些类别的广谱和窄谱抗菌剂的社区消费比例以及在该系统中使用的某些广谱抗菌剂的消费量医疗保健设置。拟议的人类指标为:耐甲氧西林和第三代头孢菌素,对氨基糖苷类,氟喹诺酮和第三代头孢菌素具有耐药性,对青霉素和大环内酯类耐药,以及对碳青霉烯类耐药。对于食用动物,抗菌素消耗的指标包括:兽用抗菌素的总体销量,第三代和第四代头孢菌素的销量,喹诺酮的销量和多粘菌素的销量。最后,针对食用动物的拟议指标包括:对预定义的一组抗菌药物的完全敏感性,含有产生/ AmpC的样品的比例,对三种或三种以上抗菌药物的耐药性以及对环丙沙星的耐药性。对于所有行业,所选指标至少应每5年重新考虑一次,预计将是监测抗菌素消费量的有效工具。除了拟议的人类指标外,这些指标通常不适合监测特定部门(例如单一动物物种或动物生产部门)中有针对性的干预措施的效果。管理决策决不能仅基于这些指标,而应考虑基础数据及其分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号